Cancer Drugs Are Being Approved Before They Work

Pharmaceutical companies have made billions from cancer drugs that were never proven to actually help patients live longer. That is not a conspiracy theory, it is what the data shows. Through the FDA accelerated approval program, new cancer treatments can reach the market before clinical trials confirm they extend survival, and in some cases those confirmations never come. On top of that, drugs that do show results are often prescribed at doses far higher than patients need, quietly padding Big Pharma profits while patients and insurers absorb the cost. This video breaks down how the fast tracking of cancer drug approvals became one of the most profitable loopholes in modern medicine, what it means for patients making real treatment decisions right now, and why the system has been so slow to change. If you want to understand how cancer treatment and pharmaceutical industry incentives actually intersect, this is a good place to start.